858-692-3573 info@denovicontx.com


While our computational platform and proprietary molecular modeling-AI algorithm are applicable to any therapeutic area and disease, we are currently focused on the discovery of novel small-molecule therapeutics for cancer. Specifically, our precision oncology approach is being applied to high-profile targets in the DNA damage response signaling pathways.